HOME >> MEDICINE >> NEWS
New data on the effect of Atacand(R) on NYHA class in a broad spectrum of heart failure patients

Mlndal, Sweden, 9 March 2004 Data presented today at the American College of Cardiology (ACC) annual meeting add weight to the evidence shown in the original publications from the CHARM* Programme of the effects of Atacand (candesartan cilexetil) in chronic heart failure (CHF) patients. The results from further analysis of the data add further support for the CHARM study as a landmark clinical research programme.

Importantly, one analysis1 found that New York Heart Association (NYHA) functional class improved in a broad spectrum of CHF patients treated with Atacand. Of all CHARM patients, 35.4% taking Atacand improved in NYHA functional class, 55.6% remained unchanged and 9% worsened. This compared with 32.5%, 57.5% and 10.3% respectively in the placebo group (p=0.004). These findings were supported by a favourable change in the Overall Treatment Evaluation in the Atacand group compared to the placebo group (p=0.01).

Commenting on this additional analysis, Professor John McMurray, principal investigator in the CHARM-Added study, Glasgow University and Western Infirmary, Glasgow, Scotland, said "Improving symptomatic well-being is a key objective of heart failure treatment. NYHA functional classification is the most widely used and validated measure of symptomatic limitation in CHF. That candesartan has been shown to improve NYHA functional class across the broad spectrum of CHF investigated in the CHARM Programme will have significant implications for clinical practice. These findings are consistent with a reduction in CHF hospitalisations".

A further analysis suggests that the development of atrial fibrillation (AF) in some patients with symptomatic chronic heart failure may also be reduced. Of the 7,601 heart failure patients in CHARM, 72.6% did not have atrial fibrillation (AF) at baseline. This new analysis found that, in the patients randomised to Atacand, new incidence of AF during the trial was 6.5%, compared to 7.9% in the place
'"/>

Contact: Mark Chamberlain
mark.chamberlain@ketchum.com
44-207-611-3649
Ketchum
9-Mar-2004


Page: 1 2

Related medicine news :

1. Strategy effective against drug resistant tuberculosis
2. Study shows patch therapy may be as effective as oral medications
3. Chronic pain treatments more effective when taken together, new study shows
4. Geodon effective in psychiatric emergencies; Sharply reduces time in restraints
5. Brain activity prior to treatment flags vulnerability to antidepressant side effects
6. Improving access to healthy food has little effect on diet
7. Storage time and temperature effects nutrients in spinach
8. Costs of antidepressants could have funded effective alternatives
9. New ways to design safer & more effective topical (transdermal) drug delivery announced in the PNAS
10. Government wasting your taxpayer money on ineffective drug cure
11. Neurobehavioral function during coma, stroke rehabilitation effective for elderly

Post Your Comments:
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Curly Hair ... 14, the largest beauty event in the US, featuring products from all over the ... Keeper™ Collection. The Collection is a line of hair styling products focused entirely on ...
(Date:6/29/2015)... Petersburg, FL (PRWEB) , ... June 30, 2015 , ... ... a special 50% Off offer. The oil, ideal for natural skincare and even ... natural and easy way is something most people desire, and Oil Pulling can accomplish ...
(Date:6/29/2015)... ... June 30, 2015 , ... The United States Equestrian Federation (USEF) ... it becomes the Official Physical and Occupational Therapists of the U.S. Eventing Team. ... Event presented by Land Rover. , “The USEF is pleased to welcome the ...
(Date:6/29/2015)... ... June 30, 2015 , ... The ... for Neuro Musculoskeletal Thermography and Sympathetic Skin Response Studies.* , The new peer-reviewed ... published in 2006, are intended to aid physicians and thermal technologists in the ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... to educate readers and potential patients about a variety of plastic surgery and ... dentistry and more. , It has been the main focus of Cosmetic Town ...
Breaking Medicine News(10 mins):Health News:Curly Hair Solutions™ Showcases Entire Curl Keeper™ Collection at Cosmoprof Las Vegas July 12 - 14 2Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2Health News:KORT Physical Therapy Announces Partnership with The United States Equestrian Federation 2Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 2Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 3Health News:Board of Advisors Now Coming to Cosmetic Town 2
(Date:6/29/2015)... , June 30, 2015 , ... Corning and Gerresheimer enter into a 10-year-supply ... amount to EUR 196m debt-free Corning and ... for the pharmaceutical glass packaging market Gerresheimer,s outlook ... reflect the future disposal of the tubing business , ...
(Date:6/29/2015)... 29, 2015 EnteroMedics Inc. (NASDAQ: ETRM ... neuroblocking technology to treat obesity, metabolic diseases, and other ... underwritten public offering of units. Each unit will consist ... to purchase common stock and Series B warrants to ... the offering would result in them beneficially owning more ...
(Date:6/29/2015)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced ... 1000 Index, effective June 26, 2015. The Russell 1000 ... the U.S. equity universe. It is a subset of ... the largest securities based on a combination of their ... are pleased to be added to this important index, ...
Breaking Medicine Technology:Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 2Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 3EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3
Cached News: